Director equity grant at Molina (NYSE: MOH) valued at $55,000

Rhea-AI Filing Summary

ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.

Director Richard C. Zoretic received a grant of 237 shares of Molina Healthcare common stock, awarded under the company’s 2025 Equity Incentive Plan for his board service. The award reflects a $55,000 quarterly portion of a $220,000 annual equity package, valued at a closing price of $232.55 per share. All 9,389 shares reported after the transaction are held indirectly through the Richard Charles Zoretic Revocable Living Trust.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ZORETIC RICHARD C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 9,389 shares (Indirect, Held by trust)

Footnotes (1)

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. Represents the closing price of the Issuer's common stock on July 1, 2026. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Key Figures

Shares granted: 237 shares Grant valuation price: $232.55 per share Quarterly equity award value: $55,000 +2 more

5 metrics

Shares granted 237 shares Equity award to director on July 1, 2026

Grant valuation price $232.55 per share Closing price on July 1, 2026 used for grant

Quarterly equity award value $55,000 One quarter of annual director equity award

Annual equity award value $220,000 Total annual equity compensation per director

Total shares after grant 9,389 shares Indirectly held via revocable living trust

Key Terms

2025 Equity Incentive Plan, annual equity award, Revocable Living Trust, indirect ownership

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Revocable Living Trust financial

"All shares held by the Richard Charles Zoretic Revocable Living Trust."

indirect ownership financial

"All shares held by the Richard Charles Zoretic Revocable Living Trust."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:54 PM Accepted by SEC EDGAR 07/02/2026 - 04:53 PM Learn about SEC filing dates

FAQ

What did Molina Healthcare (MOH) director Richard C. Zoretic report in this Form 4?

He reported receiving 237 shares of Molina Healthcare common stock as an equity grant for board service. The award came under the 2025 Equity Incentive Plan and is part of his regular director compensation structure, not an open-market purchase or sale.

How large is Richard C. Zoretic’s latest Molina Healthcare (MOH) stock grant?

The grant totals 237 shares of common stock, representing a $55,000 equity award. That amount is one quarter of his $220,000 annual equity compensation as a director, calculated using Molina Healthcare’s July 1, 2026 closing share price.

At what price was the Molina Healthcare (MOH) director equity grant calculated?

The grant was based on a closing price of $232.55 per share for Molina Healthcare common stock on July 1, 2026. Using this price, a $55,000 quarterly equity award translated into 237 shares granted to director Richard C. Zoretic.

How many Molina Healthcare (MOH) shares does Richard C. Zoretic hold after this transaction?

After the grant, he is reported as indirectly holding 9,389 shares of Molina Healthcare common stock. All of these shares are held through the Richard Charles Zoretic Revocable Living Trust, rather than in a direct personal brokerage account.

Is Richard C. Zoretic’s Molina Healthcare (MOH) stock grant an open-market trade?

No, this is a compensation-related equity award, not an open-market transaction. The 237 shares were granted under Molina Healthcare’s 2025 Equity Incentive Plan as part of his director compensation, calculated from the stock’s closing price on the grant date.

How is Molina Healthcare (MOH) director equity compensation structured in this filing?

The filing states each director’s annual equity award is set at $220,000. One quarter, or $55,000, is granted on the first day of each quarter, with share counts determined using Molina Healthcare’s common stock closing price on that specific grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	9,389	I	Held by trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

4. All shares held by the Richard Charles Zoretic Revocable Living Trust.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard C. Zoretic	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)